Business Wire
-
BioVigilant Submits Drug Master Files To U.S. FDA For Instantaneous Microbial Detection Systems
9/1/2011
BioVigilant Systems, Inc. (www.biovigilant.com), inventors of Instantaneous Microbial Detection™, announced today it has filed Type V Drug Master Files (DMFs) for its IMD-A® 300 series of rapid biologic detection systems for real-time environmental air monitoring in pharmaceutical manufacturing environments.
-
New Survey Finds Life Sciences Companies Struggling To Accurately Forecast Spending For Clinical Studies
8/1/2011
ClearTrial recently announced the results of a new survey of life sciences professionals charged with forecasting and budgeting clinical studies at small, mid-sized, and Top 20 biopharmaceutical and medical device companies.
-
Seattle Genetics Announces Antibody-Drug Conjugate Collaboration With Abbott
3/22/2011
Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that it has entered into a collaboration agreement with Abbott (NYSE:ABT) under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate (ADC) technology with antibodies to a single oncology target.
-
Mirrx Therapeutics A/S Secures Seed Financing For Development Of Novel MicroRNA-Blocking Technology
2/4/2010
Mirrx Therapeutics today announced that it has closed on a seed financing round that will enable the company to achieve in vivo proof of concept for its microRNA-blocking “Blockmir” technology, as well as to strengthen its intellectual property portfolio.
-
Pfizer Announces Global Research Network
11/9/2009
Pfizer Inc today announced its global research and development network, marking an important step in implementing a new R&D model as part of the integration of Pfizer and Wyeth.
-
Pfizer And Private Access Announce Plans To Develop Online Community To Accelerate Clinical Research
8/20/2009
Recognizing that patient participation in clinical trials is the key to progress in medical research, Pfizer Inc announced today that it has entered into a collaboration with Private Access, the innovator in privacy-enhanced search technology, to create a new online community aimed at increasing clinical trial awareness and participation.
-
Top 5 Industries Most At Risk Of Web-Based Malware
11/11/2008
ScanSafe, the pioneer and leading provider of SaaS Web Security, today releases its report ‘The Vertical Risk’ which reveals the top 5 industries at risk of Web-delivered malware as well as an analysis of the types and severity of the malware encountered.
-
Monogram Biosciences Announces HER2:HER3 Heterodimer And HER3/PI3K VeraTag™ Assays Are Now Available For Use In Development Of Cancer Therapeutics
11/11/2008
Monogram Biosciences, Inc. today announced that additional EGFR/HER assays have been successfully tested in sets of fixed human tumors and are now available for use in drug development programs.
-
INNO-406 Demonstrates Positive Clinical Responses In Phase 1 Trial In Patients With Chronic Myeloid Leukemia
11/11/2008
CytRx Corporation, today announced that INNO-406, CytRx’s potent, orally available, rationally designed, dual Bcr-Abl and Lyn-kinase inhibitor, demonstrated clinical responses in patients with Chronic Myeloid Leukemia (CML).
-
Supreme Court Decision Will Keep Biotech Sector Competitive During Tough Economic Time
11/7/2008
The Supreme Court's unanimous decision to uphold selection patents, issued today, helps keep the biotechnology sector competitive as it seeks international investment during these difficult economic times, in the view of BIOTECanada, an intervener in the case.
This website uses cookies to ensure you get the best experience on our website. Learn more